Accessibility Menu
Sirona Biochem logo

Sirona Biochem

(OTC) SRBCF

Current Price$0.00
Market CapN/A
Since IPO (2012)-100%
5 Year-100%
1 Year-100%
1 Month-100%

Sirona Biochem Financials at a Glance

Market Cap

N/A

Revenue (TTM)

-CA$16.36K

Net Income (TTM)

-CA$2.67M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

139.45 (High)

Price

$0.00

Volume

50,000

Open

$0.00

Previous Close

$0.01

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.02

Estimated Earnings Date

Apr 22, 2026

SRBCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sirona Biochem

Industry

Biotechnology

CEO

Howard Jarman Verrico, MD

Headquarters

Vancouver, BC V7X 1L4, CA

SRBCF Financials

Key Financial Metrics (TTM)

Gross Margin

-83%

Operating Margin

-69%

Net Income Margin

-73%

Return on Equity

0%

Return on Capital

3%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

0

Volume

50.00K

Avg. Volume

781.25

Financials (TTM)

Gross Profit

-CA$28.77K

Operating Income

-CA$2.41M

EBITDA

-CA$2.33M

Operating Cash Flow

-CA$1.76M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$1.76M

Cash & ST Invst.

CA$572.23K

Total Debt

CA$2.18M

Sirona Biochem Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

CA$2.54K

-62.7%

Gross Profit

CA$2.54K

-42.7%

Gross Margin

100.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

10

N/A

Net Income

-CA$885.18K

-68.4%

EBITDA

-CA$662.08K

-46.4%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

CA$33.62K

-89.1%

Total Debt

CA$3.32M

+100.0%

Accounts Receivable

CA$767.67K

+1705.4%

Inventory

CA$0.00

-100.0%

Long Term Debt

CA$1.78M

+13.9%

Short Term Debt

CA$1.54M

+1453.6%

Return on Assets

-2.46%

N/A

Return on Invested Capital

2.88%

N/A

Free Cash Flow

-CA$552.59K

-2.4%

Operating Cash Flow

-CA$552.59K

-2.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMUCEOM Pharmaceuticals Holdings, Inc.
$0.19-11.17%
NYMXFNymox Pharmaceutical Corporation
$0.10+1.36%
LVCLFAlgorae Pharmaceuticals Limited
$0.01+0.00%
PPCBPropanc Biopharma, Inc.
$2.27-6.58%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$160.95+0.19%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.04-0.02%
RKLBRocket Lab
$102.39-0.11%

Questions About SRBCF

What is the current price of Sirona Biochem?

Sirona Biochem is trading at $0.00 per share.

What is the 52-week range for Sirona Biochem?

Over the past 52 weeks, Sirona Biochem has traded between $0.00 and $0.02.

How much debt does Sirona Biochem have?

As of the most recent reporting period, Sirona Biochem reported total debt of CA$2.40M.

How much cash does Sirona Biochem have on hand?

Sirona Biochem reported CA$23.80K in cash and cash equivalents in its most recent financial results.

What is Sirona Biochem’s dividend yield?

Sirona Biochem does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.